Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors

Pediatric Epilepsy Study in Subjects 1-24 Months

NCT00044278 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures

NCT02477839 ·Status: COMPLETED ·Phase: PHASE3

Lacosamid-i.v.-Register

NCT01620840 ·Status: COMPLETED

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy

NCT01673282 ·Status: COMPLETED

Lacosamide in Preventing Seizures in Participants With Malignant Glioma

NCT01432171 ·Status: TERMINATED ·Phase: NA

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

NCT02408549 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy

NCT04144218 ·Status: UNKNOWN ·Phase: PHASE4

Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy

NCT01190098 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

NCT02408523 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994

NCT02582866 ·Status: COMPLETED ·Phase: PHASE3

LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures

NCT00144872 ·Status: COMPLETED ·Phase: PHASE1

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

NCT01118949 ·Status: COMPLETED ·Phase: PHASE2

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

NCT00520741 ·Status: COMPLETED ·Phase: PHASE3

Seizure Prophylaxis in Patients With Glioma or Brain Metastasis

NCT03436433 ·Status: TERMINATED ·Phase: PHASE2

Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure

NCT01235403 ·Status: COMPLETED ·Phase: PHASE4

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

NCT01243177 ·Status: COMPLETED ·Phase: PHASE3

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

NCT00955357 ·Status: COMPLETED ·Phase: PHASE4

A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy

NCT04737837 ·Status: UNKNOWN

A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures

NCT01710657 ·Status: COMPLETED ·Phase: PHASE3

Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures

NCT00655551 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

NCT01969851 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

NCT01118962 ·Status: COMPLETED ·Phase: PHASE2

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

NCT00552305 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

NCT02124564 ·Status: COMPLETED ·Phase: PHASE3

Lacosamide Intravenous Injection for Emergency Termination of Status Epilepticus

NCT06966830 ·Status: NOT_YET_RECRUITING